Abstract
A 2009 international survey of 128 PET/CT technologists revealed that 58% of them administered oral contrast agents as part of their protocol for “some or most patients” ([1][1]). Among those using oral contrast agents, iodine-based contrast material was administered 35% of the time. An
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.